These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31707120)

  • 21. The Antidiabetic Potential of Quercetin: Underlying Mechanisms.
    Eid HM; Haddad PS
    Curr Med Chem; 2017; 24(4):355-364. PubMed ID: 27633685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
    Tran TH; Guo Y; Song D; Bruno RS; Lu X
    J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences.
    Kumar P; Sharma G; Kumar R; Singh B; Malik R; Katare OP; Raza K
    Int J Pharm; 2016 Dec; 515(1-2):307-314. PubMed ID: 27756627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity.
    Jain S; Jain AK; Pohekar M; Thanki K
    Free Radic Biol Med; 2013 Dec; 65():117-130. PubMed ID: 23792276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life or death: neuroprotective and anticancer effects of quercetin.
    Dajas F
    J Ethnopharmacol; 2012 Sep; 143(2):383-96. PubMed ID: 22820241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use.
    Chen KTJ; Anantha M; Leung AWY; Kulkarni JA; Militao GGC; Wehbe M; Sutherland B; Cullis PR; Bally MB
    Drug Deliv Transl Res; 2020 Feb; 10(1):202-215. PubMed ID: 31482519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin- and quercetin-loaded liquid crystalline nanoparticles: implications on oral bioavailability, antidiabetic and antioxidant efficacy.
    Singh S; Kushwah V; Agrawal AK; Jain S
    Nanomedicine (Lond); 2018 Mar; 13(5):521-537. PubMed ID: 29383973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in Liposomal Drug Delivery System of Quercetin for Cancer Targeting: A Mechanistic Approach.
    Das SS; Hussain A; Verma PRP; Imam SS; Altamimi MA; Alshehri S; Singh SK
    Curr Drug Deliv; 2020; 17(10):845-860. PubMed ID: 32294036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin, Inflammation and Immunity.
    Li Y; Yao J; Han C; Yang J; Chaudhry MT; Wang S; Liu H; Yin Y
    Nutrients; 2016 Mar; 8(3):167. PubMed ID: 26999194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability.
    Kawabata K; Mukai R; Ishisaka A
    Food Funct; 2015 May; 6(5):1399-417. PubMed ID: 25761771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-delivered quercetin for cancer therapy.
    Men K; Duan X; Wei XW; Gou ML; Huang MJ; Chen LJ; Qian ZY; Wei YQ
    Anticancer Agents Med Chem; 2014; 14(6):826-32. PubMed ID: 24851877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
    Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
    J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies.
    Joshi H; Gupta DS; Kaur G; Singh T; Ramniwas S; Sak K; Aggarwal D; Chhabra RS; Gupta M; Saini AK; Tuli HS
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3443-3458. PubMed ID: 37490121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain.
    Enteshari Najafabadi R; Kazemipour N; Esmaeili A; Beheshti S; Nazifi S
    BMC Pharmacol Toxicol; 2018 Sep; 19(1):59. PubMed ID: 30253803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update.
    Khan F; Niaz K; Maqbool F; Ismail Hassan F; Abdollahi M; Nagulapalli Venkata KC; Nabavi SM; Bishayee A
    Nutrients; 2016 Aug; 8(9):. PubMed ID: 27589790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of quercetin-loaded advanced nanoformulations for the management of diabetic wounds.
    Panthi VK; Imran M; Chaudhary A; Paudel KR; Mohammed Y
    Nanomedicine (Lond); 2023 Feb; 18(4):391-411. PubMed ID: 37140389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel quercetin derivatives: From redox properties to promising treatment of oxidative stress related diseases.
    Zizkova P; Stefek M; Rackova L; Prnova M; Horakova L
    Chem Biol Interact; 2017 Mar; 265():36-46. PubMed ID: 28137512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CuS@MOF-Based Well-Designed Quercetin Delivery System for Chemo-Photothermal Therapy.
    Jiang W; Zhang H; Wu J; Zhai G; Li Z; Luan Y; Garg S
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):34513-34523. PubMed ID: 30215253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of quercetin-phospholipid complex to improve the bioavailability and protection effects against carbon tetrachloride-induced hepatotoxicity in SD rats.
    Zhang K; Zhang M; Liu Z; Zhang Y; Gu L; Hu G; Chen X; Jia J
    Fitoterapia; 2016 Sep; 113():102-9. PubMed ID: 27431774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin: potentials in the prevention and therapy of disease.
    Bischoff SC
    Curr Opin Clin Nutr Metab Care; 2008 Nov; 11(6):733-40. PubMed ID: 18827577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.